# OnCo record actm-838 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/actm-838/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "actm-838" ;
  schema:name "ACTM-838"@en ;
  schema:description "ACTM-838 is an experimental engineered attenuated Salmonella Typhimurium from Actym Therapeutics, in phase 1 trials for advanced solid tumours; its current status is not stated."@en ;
  schema:url <https://onco.cc/drugs/actm-838/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.actymthera.com/pipeline>, <https://synapse.patsnap.com/article/actym-gets-ind-clearance-for-phase-1-trial-of-actm-838-in-solid-tumor-patients>, <https://clinicaltrials.gov/api/v2/studies/NCT06336148>, <https://clinicaltrials.gov/search?intr=ACTM-838> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Engineered attenuated Salmonella Typhimurium (bacterial delivery, STACT platform)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:companies <https://onco.cc/companies/actym-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06336148/> .